← Oncology Approval Tracker

FDA DECISION ·

Lenalidomide 2.5 mg (generic Revlimid)

lenalidomide · Dr. Reddy’s Laboratories

First generic approvalFirst genericMultiple myeloma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

FDA lists a first generic Revlimid capsule approval including the 2.5 mg strength for multiple myeloma.

LAMPGEN ANALYSIS

Why it matters

The application adds the 2.5 mg strength to the first-generic record after the May approval of higher strengths.

What research teams should watch

Track strengths individually in formulary review and retain indication-specific dispensing requirements.

PRIMARY RECORDS

Sources